Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Dixon Jonathan V.GENERAL COUNSEL | Grant or award | A | — 26.1K sh | Feb 4, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,474 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Conway Kevin JohnChief Financial Officer | Option exercise | M | — 235 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Shrewsbury RondaDirector | Grant or award | A | $16K 243 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Grant or award | A | — 18.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 154.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,684 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Grant or award | A | — 7,019 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Grant or award | A | — 24.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $61K 2,970 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $8,830 200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Gummadi SuryaPresident - Americas | Open-market sale · 10b5-1 plan | SELL | $144K 1,728 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $139K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $51K 2,492 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Fox-Geen JeremyChief Financial Officer | Tax withholding | F | $248K 3,877 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Allaire JeremyDirector, Chairman and CEO | Tax withholding | F | $537K 8,404 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 2,434 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $108K 10.0K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $8,388 720 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $159K 14.7K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 250.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Russotti GregorySee Remarks | Grant or award | A | — 265.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Thompson Travis AlvinChief Financial Officer | Grant or award | A | — 58.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Randhawa SimratEVP, Head of R&D | Grant or award | A | — 150.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Cowan ChadChief Scientific Officer | Grant or award | A | — 265.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Savitz RyanEVP, CFO & CBO | Grant or award | A | — 150.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Carr DouglasSVP Finance & Operations | Grant or award | A | — 225.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Vultaggio VincentPAO and PFO | Open-market sale · 10b5-1 plan | SELL | $6,477 2,540 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | Grant or award | A | — 945.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Chuang Patrick T.Senior VP, Memory Design | Grant or award | A | — 20.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Nelson Jeffrey EdwardChief Operating Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 106.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Nelson Jeffrey EdwardChief Operating Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Naude PierreDirector | Grant or award | A | — 3,516 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Saldanha CraigChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Novack Jeffrey AdamSecretary and General Counsel | Grant or award | A | — 4,342 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Heeson LeeEVP, Head of Incyte Intl | Tax withholding | F | $11K 111 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 3 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | $50K 4,844 sh | Feb 4, 2026 traded Feb 2, 2026 |